Day: August 5, 2021

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) — Northview Canadian High Yield Residential Fund (“Northview” or the “Fund”) (NHF.UN – TSX), today announced financial results for the three and six months ended June 30, 2021. All amounts in this news release are in thousands of Canadian dollars unless otherwise indicated.“We are pleased to deliver another quarter of solid financial results, highlighted by an improvement in occupancy of 80 basis points from the previous quarter and an FFO payout ratio of 75.2%,” commented Mr. Todd Cook, Northview’s Chief Executive Officer. “Northview has continued to invest in its properties and we are well positioned to continue to deliver solid returns to our Unitholders.”HIGHLIGHTSNet and comprehensive loss...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the second quarter that ended June 30, 2021 and provided a business update. “We are encouraged by the interim results on Zeno in patients with NRG1 fusion cancers that we reported in the second quarter and remain focused on successful execution of our Zeno program and our other clinical trials,” said Bill Lundberg, M.D., President, Chief Executive Officer of Merus. “We are planning to provide a clinical update on MCLA-145 and MCLA-158 later this year.” Clinical Programs Zenocutuzumab (Zeno or MCLA-128: HER3 x HER2 Biclonics®) Phase...

CALGARY, Alberta , Aug. 05, 2021 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (the “Fund”) (TSX – EIT.UN) announces the August 2021 distribution of $0.10 per unit. The distribution will be paid on September 15, 2021 to unitholders of record on August 20, 2021. The ex-distribution date for this distribution is August 19, 2021. About Canoe EIT Income FundCanoe EIT Income Fund is one of Canada’s largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbols EIT.UN, EIT.PR.A and EIT.PR.B, and is actively managed by Robert Taylor, Portfolio Manager and Head of Equities, Canoe Financial. About Canoe Financial Canoe Financial is one of Canada’s fastest growing independent...

Net revenue guidance for 2021 increased to $435 millionNet revenue increased 13% with 7.6% organic growth 22% growth in EPS (fully diluted) 15.9% Adjusted EBITDA1 (net of IFRS 16) margin Net debt1 to Adjusted EBITDA2 multiple of less than 1 timesTORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) — IBI Group Inc. (“IBI” or the “Company”), a globally integrated design and technology firm, today announced its financial and operating results for the three and six months ended June 30, 2021. Select financial and operational information is outlined below and should be read with IBI’s consolidated financial statements (“Financial Statements”) and management’s discussion and analysis (“MD&A”) as of June 30, 2021, which are available on SEDAR at www.sedar.com and on IBI’s website at www.ibigroup.com. The Company’s second quarter 2021 results...

CALGARY, Alberta, Aug. 05, 2021 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (“Canoe” or the “Fund”) (TSX – EIT.UN, EIT.PR.A, EIT.PR.B) announces quarterly distribution on preferred units. Cumulative Redeemable Series 1 and Series 2 Preferred Unit holders will receive a distribution of $0.30 per unit. The distribution will be paid on September 15, 2021 to unitholders of record on August 20, 2021. The ex-distribution date for this distribution is August 19, 2021. About Canoe EIT Income FundCanoe EIT Income Fund is one of Canada’s largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbols EIT.UN, EIT.PR.A and EIT.PR.B, and is actively managed by Robert Taylor, Portfolio...

NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Portman Ridge Finance Corporation (NASDAQ: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the second quarter ended June 30, 2021 and declared a quarterly stockholder distribution of $0.06 per share, payable on August 31, 2021 to stockholders of record at the close of business on August 17, 2021. The Company also announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s then outstanding common stock, which is expected to be completed in the third quarter of 2021. Second Quarter 2021 HighlightsNet investment income for the quarter was $0.15 per share, or $11.7 million.Net asset value (“NAV”) per share increased to $2.93 from $2.92 quarter-to-quarter, reflecting continued favorable market conditions including...

EDMONTON, Alberta, Aug. 05, 2021 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the second quarter and six months ended June 30, 2021. Year-to-date revenue was up 49% to $108.82 million compared to the first half of 2020. Strong market demand for new homes led to 299 single-family lot sales in Canada in the first half of the year compared to 106 last year, resulting in revenue growth of 196% for the Community Development division. Investment Properties owned gross leasable area (GLA) grew by 8% as a result of properties transferred from our Property Development division over the past 12 months. Revenue in our income-producing divisions (Investment Properties and REIT) was down 2% over Q2-2020 and up 2% year-to-date. These...

BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its clinical trials of eprenetapopt in combination with azacitidine in its myeloid malignancy programs. The partial clinical hold does not apply to the Company’s ongoing clinical trials in lymphoid malignancies and solid tumors, or the APR-548 clinical trial. There are approximately 20 patients currently receiving eprenetapopt in combination with azacitidine in the Company’s myeloid malignancy programs, which includes the MDS, AML and post-transplant maintenance trials, all of which have completed enrollment....

BOTHELL, Wash., Aug. 05, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, mourns the passing of Tadataka “Tachi” Yamada, M.D., the chair of the company’s board of directors. “Yesterday, we unexpectedly lost our dear friend, Tachi,” said Mark Litton, Ph.D., MBA, Chief Operating Officer at Athira. “He was a distinguished scientist and brilliant physician who made countless contributions to the fields of science and medicine. We are truly grateful for his dedication to Athira and his support of our work. On behalf of our board and management team, we extend our deepest sympathies, strength and courage to Tachi’s family and friends during this difficult time. It has been an honor and...